These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26812695)

  • 21. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.
    Huang P; Tilley BC; Woolson RF; Lipsitz S
    Biometrics; 2005 Jun; 61(2):532-9. PubMed ID: 16011701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pair chart test for an early survival difference.
    Yin G; Zeng D
    Lifetime Data Anal; 2005 Mar; 11(1):117-29. PubMed ID: 15747593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model evaluation based on the negative predictive value for interval-censored survival outcomes.
    Han S; Tsui KW; Andrei AC
    Stat Methods Med Res; 2017 Apr; 26(2):661-673. PubMed ID: 25305195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonparametric rank-based methods for group sequential monitoring of paired censored survival data.
    Murray S
    Biometrics; 2000 Dec; 56(4):984-90. PubMed ID: 11129495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rank-sum test for clustered data when the number of subjects in a group within a cluster is informative.
    Dutta S; Datta S
    Biometrics; 2016 Jun; 72(2):432-40. PubMed ID: 26575695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring a three-armed clinical trial with survival endpoints: Fisher's least significant difference approach.
    Chen PL; Dominik R
    J Biopharm Stat; 2004 Aug; 14(3):791-801. PubMed ID: 15468765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal Scores: An Alternative to Parametric Item Response Theory and Sum Scores.
    Wiberg M; Ramsay JO; Li J
    Psychometrika; 2019 Mar; 84(1):310-322. PubMed ID: 30350132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An entropy-based nonparametric test for the validation of surrogate endpoints.
    Miao X; Wang YC; Gangopadhyay A
    Stat Med; 2012 Jun; 31(14):1517-30. PubMed ID: 22344829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple imputation for interval censored data with auxiliary variables.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2007 Feb; 26(4):769-81. PubMed ID: 16755528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2012 Dec; 12():CD005225. PubMed ID: 23235621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A robust semi-parametric warping estimator of the survivor function with an application to two-group comparisons.
    Hutson AD
    Stat Methods Med Res; 2018 Feb; 27(2):384-397. PubMed ID: 26988931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend.
    Lachin JM
    Stat Med; 2011 Nov; 30(25):3057-66. PubMed ID: 22006667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomization-based nonparametric methods for the analysis of multicentre trials.
    LaVange LM; Durham TA; Koch GG
    Stat Methods Med Res; 2005 Jun; 14(3):281-301. PubMed ID: 15969304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonparametric response-adaptive randomization for continuous responses.
    Liu Z; Hu F; Zhang LX
    Pharm Stat; 2018 Nov; 17(6):781-796. PubMed ID: 30152167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.